LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 228 filers reported holding LOXO ONCOLOGY INC in Q3 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $207,000 | -9.2% | 1,477 | +10.7% | 0.00% | 0.0% |
Q3 2018 | $228,000 | +2.7% | 1,334 | +4.1% | 0.00% | 0.0% |
Q2 2018 | $222,000 | +77.6% | 1,282 | +18.4% | 0.00% | +100.0% |
Q1 2018 | $125,000 | +37.4% | 1,083 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $91,000 | +19.7% | 1,083 | +31.3% | 0.00% | 0.0% |
Q3 2017 | $76,000 | – | 825 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital LLC | 2,038,920 | $285,592,000 | 80.87% |
DAFNA Capital Management LLC | 181,675 | $25,447,000 | 12.65% |
Opaleye Management Inc. | 175,000 | $24,512,000 | 9.15% |
Casdin Capital, LLC | 360,000 | $50,425,000 | 8.63% |
PACIFIC VIEW ASSET MANAGEMENT, LLC | 21,775 | $3,050,000 | 3.58% |
Avoro Capital Advisors LLC | 325,000 | $45,523,000 | 2.72% |
AWM Investment Company, Inc. | 70,000 | $9,805,000 | 2.13% |
Opus Point Partners Management, LLC | 6,210 | $870,000 | 1.92% |
Eventide Asset Management | 274,000 | $38,379,000 | 1.70% |
Aquilo Capital Management, LLC | 24,750 | $3,467,000 | 1.68% |